Barclays Maintains Overweight on Marex Group, Raises Price Target to $95
Benzinga Newsdesk 9 hours ago
Analyst RatingsNewsPrice Target
Barclays analyst Benjamin Budish maintains Marex Group (NASDAQ:MRX) with a Overweight and raises the price target from $92 to $95.
Barclays analyst Benjamin Budish maintains Marex Group (NASDAQ:MRX) with a Overweight and raises the price target from $92 to $95.